Literature DB >> 25674245

Interaction between fatty acid synthase and human epidermal growth receptor 2 (HER2) in osteosarcoma cells.

Xin Hua Long1, Kai Zhao1, Guo Mei Zhang2, Yang Zhou1, Rong Ping Zhou2, Zhi Li Liu1, Zhi Hong Zhang1.   

Abstract

Elevated expression of fatty acid synthase (FASN) and human epidermal growth factor receptor-2 (HER2) are observed in human osteosarcoma (OS). The aim in this study is to investigate a possible connection between FASN expression and the activity of HER2. The immunohistochemistry staining was conducted on 24 OS specimens from patients, which revealed a significant positive correlation between FASN and HER2 as well as p-HER2 protein expression. Furthermore, the human OS cell lines MG-63 and U2-OS were treated with FASN-specific RNAi Plasmid or Lapatinib (an inhibitor of HER2). The mRNA of HER2 and FASN was measured using RT-PCR. Western blot was performed to detect the protein expression of HER2, p-HER2 and FASN. The results demonstrated that HER2 modulates FASN expression, inhibition of FASN resulted in down-regulation of HER2 and p-HER2 protein in OS cells. Our findings suggested that there was positive feedback regulation between FASN and HER2 expression and phosphorylation in OS cells.

Entities:  

Keywords:  FASN; HER2; Osteosarcoma; positive feedback regulation

Mesh:

Substances:

Year:  2014        PMID: 25674245      PMCID: PMC4313995     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  23 in total

1.  Inhibition of fatty acid synthase suppresses U-2 OS cell invasion and migration via downregulating the activity of HER2/PI3K/AKT signaling pathway in vitro.

Authors:  Tao Fang Wang; Heng Wang; Ai Fen Peng; Qing Feng Luo; Zhi Li Liu; Rong Ping Zhou; Song Gao; Yang Zhou; Wen Zhao Chen
Journal:  Biochem Biophys Res Commun       Date:  2013-09-13       Impact factor: 3.575

2.  Human epidermal growth factor receptor 2 as a prognostic indicator in osteogenic sarcoma.

Authors:  C D Morris; R Gorlick; G Huvos; G Heller; P A Meyers; J H Healey
Journal:  Clin Orthop Relat Res       Date:  2001-01       Impact factor: 4.176

3.  Fatty acid synthase overexpression in adult testicular germ cell tumors: potential role in the progression of non-seminomatous germ cell tumors.

Authors:  Kosuke Miyai; Keiichi Iwaya; Tomohiko Asano; Seiichi Tamai; Osamu Matsubara; Hitoshi Tsuda
Journal:  Virchows Arch       Date:  2013-12-14       Impact factor: 4.064

4.  Fatty acid synthase expression in osteosarcoma and its correlation with pulmonary metastasis.

Authors:  Zhi Li Liu; Gao Wang; Ai Fen Peng; Qing Feng Luo; Yang Zhou; Shan Hu Huang
Journal:  Oncol Lett       Date:  2012-08-14       Impact factor: 2.967

5.  Overexpression of fatty acid synthase in human gliomas correlates with the WHO tumor grade and inhibition with Orlistat reduces cell viability and triggers apoptosis.

Authors:  Susanne Grube; Pedro Dünisch; Diana Freitag; Maren Klausnitzer; Yasser Sakr; Jan Walter; Rolf Kalff; Christian Ewald
Journal:  J Neurooncol       Date:  2014-05-01       Impact factor: 4.130

Review 6.  Emerging approaches for treating HER2-positive metastatic breast cancer beyond trastuzumab.

Authors:  W J Gradishar
Journal:  Ann Oncol       Date:  2013-07-04       Impact factor: 32.976

7.  Inhibition of fatty acid synthase suppresses osteosarcoma cell invasion and migration via downregulation of the PI3K/Akt signaling pathway in vitro.

Authors:  Zhi Li Liu; Jian Hua Mao; Ai Fen Peng; Qing Shui Yin; Yang Zhou; Xin Hua Long; Shan Hu Huang
Journal:  Mol Med Rep       Date:  2012-12-03       Impact factor: 2.952

8.  Quantitative assessment of HER2/neu expression by real-time PCR and fluorescent in situ hybridization analysis in low-grade osteosarcoma.

Authors:  Woo-In Lee; Patrizia Bacchni; Franco Bertoni; Young Hee Maeng; Yong-Koo Park
Journal:  Oncol Rep       Date:  2004-07       Impact factor: 3.906

9.  Combination of antibody that inhibits ligand-independent HER3 dimerization and a p110α inhibitor potently blocks PI3K signaling and growth of HER2+ breast cancers.

Authors:  Joan T Garrett; Cammie R Sutton; Richard Kurupi; Carl Uli Bialucha; Seth A Ettenberg; Scott D Collins; Qing Sheng; Jerry Wallweber; Lisa Defazio-Eli; Carlos L Arteaga
Journal:  Cancer Res       Date:  2013-08-05       Impact factor: 12.701

10.  Loss of fatty acid synthase inhibits the "HER2-PI3K/Akt axis" activity and malignant phenotype of Caco-2 cells.

Authors:  Nan Li; Heng Lu; Chunyan Chen; Xiaodong Bu; Peilin Huang
Journal:  Lipids Health Dis       Date:  2013-06-01       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.